North America dominates the immunohematology market North America currently leads the immunohematology market, commanding a substantial market share of over 40.2% in 2024. This dominance can be attributed to the region's advanced healthcare infrastructure, robust research and development initiatives, and a high demand for precision diagnostics. The presence of leading manufacturers and suppliers of immunohematology products contributes to the region's strong market position. Additionally, the growing prevalence of blood-related disorders and the increasing number of blood transfusions drive the need for efficient and accurate immunohematology testing solutions. As healthcare providers increasingly adopt advanced technologies to improve patient care and safety, North America is expected to maintain its leadership in the immunohematology market. #marketresearch #business #marketanalysis #markettrends #researchreport #marketreport #marketforecast #marketanalysis #marketgrowth #imarcgroup Grab a sample pdf: https://www.imarcgroup.com/immunohematology-market